Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRACkER trial of triple therapy versus dual therapy in COPD patients with asthma features
2019-003351-11Phase 4Active
- Sponsor
- General Practitioners Research Institute
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of beclometasone dipropionate/formoterol fumarate/glycopyrronium in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by General Practitioners Research Institute. Started Dec 2019; status: active.
02
Drugs
beclometasone dipropionate/formoterol fumarate/glycopyrronium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2019-003351-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003351-11.